Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: May Letter to Shareholders from Patriot Scientific President and CEO Rick Goerne

IMO Judge Ward holds the MOU that will require the J's to pay more money for the license when/if the USPTO revalidates the patents. Until then the J's are granted a license to continue selling goods that utilize the MMP patents. If the patents are not re-validated then the J's and all remaining companies will not need to pay for a license period. Come on USPTO!

All the best,

Steve

Share
New Message
Please login to post a reply